The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Ficoxil 227 mg chewable tablets for dogs

LIVISTO Int'l, S.L.VPA10425/016/002

Main Information

Trade NameFicoxil 227 mg chewable tablets for dogs
Active SubstancesFirocoxib
Dosage FormChewable tablet
Licence HolderLIVISTO Int'l, S.L.
License Holder AddressAv. Universitat Autònoma, 29
08290 Cerdanyola del Vallès
Licence NumberVPA10425/016/002

Group Information

ATC CodeQM01AH90 firocoxib
Therapeutic ClassN.S.A.I.D.


License statusAuthorised
Licence Issued18/06/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back